Skip to main content
. 2020 Oct 12;43(1):470–499. doi: 10.1002/hbm.25204

TABLE 1.

Sex distributions and age of subjects by sample

Sample Total N Sex N Age
Mean SD Range
EDINBURGH 55 Male 20 23.9 2.5 18.5–28.4
Female 35 23.7 3.1 18.6–30.6
UNIBA 131 Male 67 30.3 10.0 18.0–63.0
Female 64 24.3 6.8 18.0–52.0
Tuebingen 50 Male 22 38.4 11.1 26.0–61.0
Female 28 42.2 12.5 24.0–61.0
GSP 2009 Male 894 27.8 16.8 18.0–90.0
Female 1115 26.7 16.2 18.0–89.0
Melbourne 102 Male 54 19.5 2.9 15.0–25.0
Female 48 19.6 3.1 15.0–26.0
HMS 55 Male 21 41.3 11.2 24.0–59.0
Female 34 38.5 12.8 19.0–64.0
ENIGMA‐OCD (1) 66 Male 30 30.6 8.9 19.0–56.0
Female 36 35.1 10.9 18.0–61.0
NUIG 93 Male 54 34.1 11.6 18.0–57.0
Female 39 39.0 11.0 18.0–58.0
NeuroIMAGE 383 Male 177 16.8 3.6 7.7–28.5
Female 206 17.0 3.8 7.8–28.6
CAMH 141 Male 72 43.2 18.9 18.0–86.0
Female 69 44.1 19.8 18.0–82.0
Basel 44 Male 17 25.7 4.5 19.0–35.0
Female 27 25.3 4.2 19.0–39.0
Bordeaux 452 Male 220 26.9 7.8 18.0–57.0
Female 232 26.6 7.7 18.0–56.0
FBIRN 174 Male 124 37.6 11.3 19.0–60.0
Female 50 37.4 11.3 19.0–58.0
KaSP 32 Male 15 27.4 5.5 21.0–43.0
Female 17 27.6 5.9 20.0–37.0
CODE 72 Male 31 43.7 12.4 25.0–64.0
Female 41 36.6 13.4 20.0–63.0
Indiana (1) 49 Male 9 71.9 6.6 63.0–80.0
Female 40 60.4 11.6 37.0–84.0
COMPULS/TS EUROTRAIN 53 Male 36 10.8 1.0 8.7–12.9
Female 17 11.0 1.1 9.2–12.9
FIDMAG 123 Male 54 36.4 8.5 19.0–63.0
Female 69 38.4 11.2 19.0–64.0
NU 79 Male 46 31.6 14.5 14.6–66.3
Female 33 34.4 15.3 14.2–67.9
SHIP‐TREND 818 Male 467 50.5 14.4 22.0–81.0
Female 351 49.6 14.0 21.0–81.0
SHIP‐2 373 Male 207 55.6 12.8 31.0–84.0
Female 166 54.4 12.0 32.0–88.0
QTIM 340 Male 111 22.5 3.3 16.0–29.3
Female 229 22.7 3.4 16.1–30.0
Betula 287 Male 136 61.6 12.5 25.5–81.3
Female 151 64.1 13.1 25.7–80.9
TOP 303 Male 159 34.5 8.8 18.3–56.2
Female 144 36.3 10.9 19.3–73.4
HUBIN 102 Male 69 42.1 9.0 19.4–54.9
Female 33 41.7 8.5 19.9–56.2
StrokeMRI 52 Male 19 47.9 20.8 20.0–77.0
Female 33 43.6 23.0 18.0–78.0
AMC 99 Male 65 22.5 3.4 17.0–32.0
Female 34 23.6 3.3 18.0–29.0
NESDA 65 Male 23 40.7 9.7 23.0–56.0
Female 42 40.1 9.9 21.0–54.0
Barcelona (1) 30 Male 14 15.1 1.5 13.0–17.0
Female 16 14.9 2.1 11.0–17.0
Barcelona (2) 44 Male 24 14.4 1.8 11.0–17.0
Female 20 14.8 2.4 11.0–17.0
Stages‐Dep 32 Male 9 46.6 8.4 37.0–58.0
Female 23 45.8 8.2 27.0–58.0
IMpACT 144 Male 57 34.2 11.0 19.0–62.0
Female 87 37.2 12.6 19.0–63.0
BIG 1319 Male 657 29.8 15.4 17.0–82.0
Female 662 26.9 12.9 13.0–79.0
IMH Stanford 56 Male 22 36.0 10.5 20.4–60.5
34 Female 34 37.5 10.8 18.9–56.3
MCIC (1) + (2) 93 Male 63 32.8 12.2 18.0–58.0
Female 30 32.5 11.9 19.0–60.0
OLIN 599 Male 237 36.3 13.3 22.0–86.5
Female 362 35.9 12.8 21.0–74.0
Neuroventure 137 Male 62 13.7 0.6 12.4–14.9
Female 75 13.6 0.7 12.3–14.9
CIAM 30 Male 16 27.1 5.9 19.0–40.0
Female 14 26.1 3.8 20.0–33.0
ENIGMA‐HIV 31 Male 16 25.6 4.7 19.0–33.0
Female 15 23.9 4.1 20.0–32.0
Meth‐CT 62 Female 13 26.1 4.1 19.0–34.0
Males 49 27.0 7.9 18.0–53.0
ENIGMA‐OCD 26 Male 10 34.6 13.6 19.0–56.0
Female 16 28.8 7.8 20.0–46.0
Oxford 38 Male 18 16.5 1.6 14.1–18.9
Female 20 15.9 1.1 13.7–17.7
Yale 23 Male 12 14.4 2.4 10.3–17.5
Female 11 14.0 2.0 9.9–16.5
Sao Paulo‐1 69 Male 45 27.1 5.6 18.0–42.0
Female 24 27.5 6.4 17.0–43.0
Sao Paulo‐3 85 Male 45 28.2 7.3 18.0–43.0
Female 40 32.7 8.8 18.0–50.0
ENIGMA‐OCD (2) 49 Male 19 32.1 7.8 24.0–53.0
Female 30 31.3 7.7 21.0–50.0
ENIGMA‐OCD (3) 35 Male 16 42.9 12.9 22.5–64.0
Female 19 36.0 8.8 21.5–49.3
ENIGMA‐OCD (4) 23 Male 9 13.1 2.9 8.8–15.9
Female 14 13.8 2.4 8.7–16.8
ENIGMA‐OCD (5) 33 Male 12 30.7 8.8 21.0–53.0
Female 21 39.2 11.5 24.0–63.0
SYDNEY 157 Male 65 42.0 22.4 12.0–84.0
Female 92 37.1 21.7 13.0–78.0
IMH 79 Male 50 30.7 8.3 23.0–53.9
Female 29 34.2 12.4 20.4–59.0
UPENN 187 Male 86 35.7 12.9 18.0–71.0
Female 101 35.8 14.7 16.0–85.0
ADHD‐NF 13 Male 7 13.3 1.2 11.9–14.8
Female 6 13.4 0.8 12.1–14.2
Indiana (2) 66 Male 26 40.2 15.3 19.0–65.0
Female 40 39.4 14.1 20.0–65.0
Sydney MAS 523 Male 236 78.3 4.6 70.3–89.8
Female 287 78.5 4.7 70.5–90.1
OADS (1) 118 Male 39 73.8 5.5 65.0–84.0
Female 79 70.4 5.6 65.0–84.0
Cardiff 318 Male 89 28.1 7.8 19.0–57.0
Female 229 24.2 7.0 18.0–58.0
CEG 32 Male 32 15.6 1.7 13.0–19.0
NYU 51 Male 31 30.2 7.7 18.8–46.0
Female 20 31.4 10.3 19.8–51.9
CLiNG 321 Male 131 25.5 5.4 19.0–58.0
Female 190 24.9 5.1 18.0–57.0
NTR (1) 112 Male 42 28.5 8.0 19.0–56.0
Female 70 37.0 10.5 19.0–57.0
NTR (2) 30 Male 11 28.4 3.6 22.0–33.0
Female 19 28.6 9.8 1.0–42.0
NTR (3) 37 Male 14 15.1 1.5 12.0–17.0
Female 23 14.5 1.4 11.0–18.0
Indiana (2) + (3) 201 Male 97 21.6 14.4 6.0–79.0
Female 104 33.0 22.8 7.0–87.0
BIG 1291 Male 553 25.1 9.3 18.0–71.0
Female 738 23.3 6.9 18.0–66.0
OADS (2) 35 Male 15 70.1 5.7 65.0–81.0
Female 20 67.4 3.8 65.0–78.0
OADS (3) 153 Male 59 70.3 4.2 65.0–81.0
Female 94 69.7 4.6 65.0–81.0
OADS (4) 108 Male 30 69.8 4.5 65.0–85.0
Female 78 70.1 4.9 65.0–89.0
MHRC 52 Male 52 22.3 2.9 16.1–27.6
BRAINSCALE 277 Male 146 10.1 1.5 9.0–15.0
Female 131 9.9 1.2 9.0–14.1
Leiden 611 Male 299 16.2 4.7 8.3–28.1
Female 312 16.9 4.9 8.4–28.9
IMAGEN 1964 Male 952 14.5 0.4 13.2–15.7
Female 1012 14.5 0.4 13.3–16.0
ENIGMA‐HIV 175 Male 175 38.8 6.5 29.0–50.0
UMCU 172 Male 84 40.2 16.5 18.0–80.0
Female 88 39.2 17.9 18.0–84.0